Solesis Appoints John Witkowski as Chief Executive Officer

Telford, PASolesis announced today the appointment of John Witkowski as the company’s Chief Executive Officer.

Mr. Witkowski brings nearly 30 years of experience across the medical device and biopharmaceutical industries. Most recently he served as President of DSM Biomedical, the global biomaterials division of dsm-firmenich, where he led a significant period of transformational growth for DSM Biomedical.

Mr. Witkowski is well positioned to lead Solesis in its next phase of growth and brings a strong track record of building high-quality businesses, both organically and through M&A. The Solesis board welcomes Mr. Witkowski and is excited about working with him to grow Solesis and its subsidiaries, Secant Group, Polyzen, and Charter Medical.

About Solesis:

Solesis is a leader specializing in biomaterials for the life sciences industry. Operating through its subsidiaries Secant Group, Polyzen, and Charter Medical, Solesis develops and manufactures critical components and technologies for the medical device and biopharmaceutical industries. Headquartered in Telford, Pennsylvania, Solesis employs more than 450 people across five production facilities located in Pennsylvania and North Carolina. For more information, please visit